This Pharma Company Stays Innovative by Doing Two Things
Harvard Business Review
MARCH 14, 2017
This may sound obvious, but it was in sharp contrast to typical patterns in the pharma industry of recruiting from within, resistance to new thinking, and sclerotic bureaucratic structures. Roivant’s second innovation initiative was to forcefully inject an openness to fresh thinking and outside practices.
Let's personalize your content